From: HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen
 | Type 1 diabetics n = 39: 15 M/24 F | Nondiabetic controls n = 52: 21 M/31F |  |  | ||
---|---|---|---|---|---|---|
 | Frequency (Proportion and %) |  |  | |||
HLA | M | F | M | F | p | Odds ratio (95 % CI) |
DR3 | 3 (7.69) | 7 (17.9) | 5 (9.62) | 9 (17.31) | 0.2646a | 0.95 (0.48–1.87) |
 | 10 (25.64) | 14 (26.92) | 1.000 |  | ||
DR4 | 4 (10.26) | 9 (23.08) | 6 (11.54) | 4 (7.69) | 0.0085 a, * | 2.10 (1.04–4.24) |
 | 13 (33.33) | 10 (19.23) | 0.0361* |  | ||
DR3DR4 | 4 (10.26) | 4 (10.26) | 2 (3.85) | 7 (13.46) | 0.0699a | 1.30 (0.60–2.80) |
 | 8 (20.51) | 9 (17.31) | 0.5887 |  | ||
DR3 and/or DR4 | 11 (28.21) | 20 (51.28) | 13 (25.0) | 20 (38.46) | 0.5791a | 2.21 (1.13–4.36) |
 | 31 (79.49) | 33 (63.46) | 0.0194* |  | ||
X/X | 4 (10.26) | 4 (10.26) | 8 (15.38) | 11 (21.15) | 0.0111 a, * | - |
 | 8 (20.51) | 19 (36.54) | 0.0194* |  |